SWOG clinical trial number
SWOG-9515 (RTOG-9501)
Phase III Intergroup Trial of Surgery Followed by (1) Radiotherapy vs. (2) Radiochemotherapy for Resectable High Risk Squamous Cell Carcinoma of the Head and Neck
Abbreviated Title
Phase III Intergroup Trial of Surgery Followed by (1) Radiotherapy vs. (2) Radiochemotherapy for Resectable High Risk Squamous Cell Carcinoma of the Head and Neck
2004
Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck
JS Cooper;TF Pajak;AA Forastiere;J Jacobs;BH Campbell;SB Saxman;JA Kish;HE Kim;AJ Cmelak;M Rotman;M Machtay;JF Ensley;KSC Chao;CJ Schultz;N Lee;KK Fu New England Journal of Medicine 350(19):1937-1944
2002
Postoperative concurrent radiochemotherapy in high-risk SCCA of the head and neck: initial report of RTOG 9501/intergroup phase III trial
JS Cooper;TF Pajak;AA Forastiere;J Jacobs;SB Saxman;JA Kish;HE Kim;AJ Cmelak;M Rotman;M Machtay;JF Ensley;KSC Chao;CJ Schultz;N Lee;KK Fu Proc of the American Society of Clinical Oncology 21:226a(#903)
Patterns of failure for resected advanced head & neck cancer treated by concurrent chemotherapy and radiation therapy: an analysis of RTOG 9501/Intergroup Phase III trial
JS Cooper;T Pajak;AA Forastiere;J Jacobs;SB Saxman;JA Kish;HE Kim;AJ Cmelak;M Rotman;M Machtay;JF Ensley;KC Chao;CJ Schultz;N Lee;KK Fu Int J Radiat Oncol Biol Phys 54(2):2(#3)
